When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?

Dual antiplatelet therapy is a well-established treatment in patients with non-ST elevation acute coronary syndrome (NSTE-ACS), with class I of recommendation (level of evidence A) in current national and international guidelines. Nonetheless, these guidelines are not precise or consensual regarding...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Arq Bras Cardiol
Hlavní autoři: Silva, Pedro Gabriel Melo de Barros e, Ribeiro, Henrique Barbosa, Baruzzi, Antônio Claudio do Amaral, da Silva, Expedito Eustáquio Ribeiro
Médium: Artigo
Jazyk:Inglês
Vydáno: Sociedade Brasileira de Cardiologia - SBC 2016
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4811279/
https://ncbi.nlm.nih.gov/pubmed/27027367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5935/abc.20160042
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky